Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
AdvanSix
ASIX
$431M
| $471K | ﹤0.01% |
12,301
+6,612
| +116% | +$265K |
|
2052
Live Oak Bancshares
LOB
$1.99B
| $470K | ﹤0.01% |
19,306
+6,253
| +48% | +$196K |
|
|
RC
2053
Ready Capital
RC
$296M
| $470K | ﹤0.01% |
46,188
+24,518
| +113% | +$287K |
|
2054
Coeur Mining
CDE
$19.3B
| $468K | ﹤0.01% |
117,520
+67,959
| +137% | +$236K |
|
2055
The Greenbrier Companies
GBX
$1.42B
| $467K | ﹤0.01% |
14,501
+7,843
| +118% | +$237K |
|
2056
Pliant Therapeutics
PLRX
$65M
| $466K | ﹤0.01% |
+17,517
| New | +$499K |
|
|
LADR
2057
Ladder Capital
LADR
$1.26B
| $465K | ﹤0.01% |
49,207
+27,187
| +123% | +$288K |
|
2058
Vicor
VICR
$10.2B
| $464K | ﹤0.01% |
9,884
-2,167
| -18% | -$120K |
|
|
HSII
2059
DELISTED
Heidrick & Struggles
HSII
| $463K | ﹤0.01% |
15,270
+6,686
| +78% | +$205K |
|
2060
Rocket Pharmaceuticals
RCKT
$378M
| $463K | ﹤0.01% |
27,030
+13,380
| +98% | +$262K |
|
2061
Columbus McKinnon
CMCO
$559M
| $463K | ﹤0.01% |
+12,463
| New | +$452K |
|
2062
Apogee Enterprises
APOG
$893M
| $462K | ﹤0.01% |
10,690
+5,434
| +103% | +$244K |
|
2063
Telephone and Data Systems
TDS
$3.83B
| $461K | ﹤0.01% |
43,872
+24,251
| +124% | +$283K |
|
2064
Lucid Motors
LCID
$2.57B
| $461K | ﹤0.01% |
5,733
-23
| -0.4% | -$2.04K |
|
2065
Utz Brands
UTZ
$1.25B
| $461K | ﹤0.01% |
27,959
+15,471
| +124% | +$256K |
|
2066
Krispy Kreme
DNUT
$574M
| $459K | ﹤0.01% |
29,566
+15,741
| +114% | +$204K |
|
2067
Quanex
NX
$993M
| $459K | ﹤0.01% |
+21,304
| New | +$511K |
|
|
KDNY
2068
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $458K | ﹤0.01% |
19,796
+9,808
| +98% | +$234K |
|
2069
Virgin Galactic
SPCE
$497M
| $457K | ﹤0.01% |
5,648
+3,653
| +183% | +$364K |
|
2070
Healthcare Services Group
HCSG
$1.47B
| $457K | ﹤0.01% |
32,938
+17,767
| +117% | +$234K |
|
2071
Preferred Bank
PFBC
$1.27B
| $455K | ﹤0.01% |
8,311
+5,284
| +175% | +$357K |
|
2072
Southside Bancshares
SBSI
$974M
| $455K | ﹤0.01% |
13,728
+7,374
| +116% | +$269K |
|
|
ARGO
2073
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $453K | ﹤0.01% |
+15,467
| New | +$438K |
|
2074
Merchants Bancorp
MBIN
$2.51B
| $452K | ﹤0.01% |
17,378
+7,776
| +81% | +$215K |
|
2075
National Bank Holdings
NBHC
$1.93B
| $452K | ﹤0.01% |
13,513
+7,296
| +117% | +$291K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.